Vanguard Group Inc Hcw Biologics Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Hcw Biologics Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 243,158 shares of HCWB stock, worth $1.62 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
243,158
Previous 37,677
545.38%
Holding current value
$1.62 Million
Previous $16,000
17037.5%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding HCWB
# of Institutions
16Shares Held
1.16MCall Options Held
0Put Options Held
0-
Avantax Planning Partners, Inc.280KShares$1.86 Million0.11% of portfolio
-
Geode Capital Management, LLC Boston, MA237KShares$1.58 Million0.0% of portfolio
-
Cresset Asset Management, LLC Chicago, IL132KShares$877,7330.01% of portfolio
-
Pullen Investment Management, LLC Bradenton, FL75.1KShares$499,5210.01% of portfolio
-
J.W. Cole Advisors, Inc.53.4KShares$355,1230.02% of portfolio
About HCW Biologics Inc.
- Ticker HCWB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,833,100
- Market Cap $238M
- Description
- HCW Biologics Inc., a preclinical stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases. The company's lead products include HCW9218, which is an injectable immunotherapeutic for patients with pancreatic, ovarian, breast, prostate, and colorectal...